Skip to main content
Subscribe
  • Login
  • My Account
  • Logout
  • Register For Free
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HLTH 2024
    • Sponsored Content: Vital Signs Blog
  • Opinion
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • 40 Under 40
    • Best Places to Work in Healthcare
    • Healthcare Marketing Impact Awards
    • Innovators Awards
    • Diversity Leaders
    • Leading Women
    • Best in Business Awards
    • The 2030 Playbook Conference
    • Innovations in Patient Experience
    • Leading Women Conference & Awards Luncheon
    • Leadership Summit
    • Workforce Summit
    • Best Places to Work Awards Gala
    • Diversity Leaders Gala
    • - Looking Ahead to 2025
    • - Financial Growth
    • - Hospital of the Future
    • - Value Based Care
    • - Looking Ahead to 2026
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Skilled Nursing Facilities
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
    • Sponsored Content
MENU
Breadcrumb
  1. Home
  2. Safety & Quality
January 23, 2021 12:00 AM

Want more diversity in clinical trials? Start with the researchers

Steven Ross Johnson
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    An older man wearing a mask receiving a vaccine.
    Getty Images

    In the coming months, the selection of COVID vaccines is expected to be plentiful.

    A total of 20 of the more than 60 vaccine candidates in development were in Phase 3 clinical trials as of Jan. 20, according to the World Health Organization. A number of those are likely to join the two currently in use and the most promising candidates from drugmakers like Johnson & Johnson and AstraZeneca that are only weeks away from gaining approval in the U.S.

    But there’s one thing that’s missing.

    Black patients represented 10% and Latinos 13% of participants in the Phase 3 clinical trial studies for the vaccine developed by Pfizer and BioNTech. Black patients also made up 10% of participants in the Moderna vaccine trial while Latinos accounted for 20%.

    Those studies reflect the higher end of minority representation in coronavirus clinical trials. Trial data for the vaccine candidate being developed by Johnson & Johnson’s Janssen Pharmaceuticals found Black patients made up only 5% of all participants ages 55 and under while Latino patients accounted for 4%.

    The low rate of Black and Latinos patients in the coronavirus vaccine studies underscores a long-standing problem: racial and ethnic minorities represent on average about 17% of participants in industry-sponsored clinical trials despite making up a third of the population.

    While Black and Latino individuals are more than three times as likely to be hospitalized and more than twice as likely to die from COVID-19 as white patients, both groups were underrepresented in many of the vaccine clinical trials.

    Several drug companies are investing in educational outreach programs to recruit more minorities trial enrollees.

    But some think there’s another way to increase diversity.

    “Creating a more diverse clinical research pool starts with a more diverse clinical research workforce,” said Jim Kremidas, executive director for the Association of Clinical Research Professionals. “We have to address the need for more clinical research professionals to keep up with the growing number of trials and ensure those trials are more representative of all our communities.”

    Last November, ACRP expanded its digital campaign to attract racial and ethnic minority college students.

    The association is encouraging minority high school juniors and seniors and college freshmen to search the organization’s website to learn about schools offering degrees in clinical research as well as information to help them get started in their careers with a list of training and internship programs.

    Researchers seek new ways to broaden clinical trial enrollment

    In January, Parexel, a contract research organization that provides drugmakers with clinical trial supports like patient management, hired the company’s first chief patient officer as a means of enhancing clinical trial diversity.

    A spokeswoman for Johnson & Johnson, which is developing a single-dose coronavirus vaccine through its subsidiary Janssen Pharmaceuticals, said the company has launched several of its own initiatives, including a webinar program to educate pharmacists on the importance of participation diversity as well as a series of community outreach sessions to answer patients questions about clinical trials.

    Last November, the Food and Drug Administration released guidance calling for industry stakeholders to address challenges in enrolling patients from underserved communities.

    Actions the agency suggested to drugmakers included reducing transportation burdens by either providing patients assistance to get to clinic visits or by reducing their number of visits, broadening clinical trial enrollment eligibility criteria, and working with patient advocacy organizations.

    “Simply saying clinical trial diversity is ‘important’ is not enough,” said Peyton Howell, Parexel’s executive vice president and chief commercial and strategy officer, in a statement. “To correct the disparities in healthcare and drive more inclusion in clinical trials, we first must achieve a more holistic understanding of the non-medical factors that influence patient lives.”

    Also in January, Parexel announced it was partnering with Signify Health on a new initiative to improve patient diversity in clinical trials by identifying social needs that might inhibit minorities from participating in studies and connecting them with local resources.

    A review conducted last year by ACRP examining workforce shortages in clinical research found that while the rate of studies had increased by about 12% over the past several years, the workforce had grown by only 9% annually over that period.

    “For years and years we’ve heard that we don’t have enough investigators, we don’t have enough study coordinators, we don’t have enough site monitors,” Kremidas said.

    While educational tools like webinars and outreach campaigns were important for recruitment, Kremidas said improving diversity among the more than 10,000 clinical trial investigators, coordinators, monitors and site managers who make up the clinical research workforce could attract more diverse populations to participate in important clinical studies like coronavirus vaccine trials.

    Kremidas could not provide information on what share of clinical research professionals were minorities. But he contended the need for clinical research institutions to improve the diversity of their workforce was equally important to the efforts hospitals are taking to recruit more minority healthcare professionals as a way of providing care that is more culturally sensitive to a wider array of patients.

    Experts contend that having a diverse population of clinical trial participants is critical to narrow racial health disparities by allowing developers to view the full range of risks and benefits of medical products. Yet a 2019 study conducted by the Tufts Center for the Study of Drug Development found that nearly 20% of all drug and biologic products approved by the Food and Drug Administration between 2007 and 2017 had missing data on the race of clinical trial participants and that half of drug approvals did not include information on the ethnicity of participants. The FDA does not require drugmakers to include women and minorities in their trials.

    While efforts to increase diversity within the healthcare workforce have produced a variety of programs, such as mentoring and incentive initiatives for minority students to pursue careers in STEM fields, Kremidas acknowledged clinical research has lacked a similar focus in recruiting. Unlike working at a hospital, the public has largely lacked an understanding of the career opportunities that exist within clinical research.

    It’s a problem that has largely been self-inflicted. Kremidas acknowledged that for many professionals, their careers in clinical research often began by chance.

    “It’s very haphazard and serendipitous,” Kremidas said. “People don’t recognize clinical research as a career until they actually get into it or know someone who does it.”

    For its part, the Pharmaceutical Research and Manufacturers of America recently flagged workforce diversity as part of a broader goal of improving clinical trial participant diversity when it released an updated version of its Principles on Conduct of Clinical Trial and Communication of Clinical Trial Results last October. The revised principles will take effect in April.

    “A pool of diverse investigators can serve as a trusted and knowledgeable source of information for underrepresented diverse populations,” the document stated.

    One of the companies that has committed to adhering to the new PhRMA principles is pharmaceutical giant Merck, which said in a statement the company was “… taking a strong stand on addressing the systemic issues that have deterred mainly Black and Brown communities particularly in the United States from participating in clinical trials, so that those who want to participate can participate.”

    “We recognize that we have a responsibility to address the needs of an increasingly diverse set of patients, customers, employees and partners,” the company stated. “Since clinical trials function as the gatekeeper to bringing new medicines safely to patients and communities, nowhere is it more important that we have diverse representation than in our research efforts.”

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    patient nurse grade
    Leapfrog hospital grades improve with help from AI, tech
    Leapfrog grades hospital
    Leapfrog makes updates to annual hospital survey
    Most Popular
    1
    UnitedHealth Group to cut Medicare drug plan commissions
    2
    Best Places to Work in Healthcare - 2025 (alphabetical list)
    3
    GE HealthCare debuts new MRI for cardiac and oncology imaging
    4
    Here are new state healthcare laws taking effect in 2025
    5
    Investors welcome a maturing digital health market
    Sponsored Content
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2025. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HLTH 2024
      • Sponsored Content: Vital Signs Blog
    • Opinion
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • 40 Under 40
        • Best Places to Work in Healthcare
        • Healthcare Marketing Impact Awards
        • Innovators Awards
        • Diversity Leaders
        • Leading Women
        • Best in Business Awards
      • Conferences
        • The 2030 Playbook Conference
        • Innovations in Patient Experience
        • Leading Women Conference & Awards Luncheon
        • Leadership Summit
        • Workforce Summit
      • Galas
        • Best Places to Work Awards Gala
        • Diversity Leaders Gala
      • Virtual Briefings
        • - Looking Ahead to 2025
        • - Financial Growth
        • - Hospital of the Future
        • - Value Based Care
        • - Looking Ahead to 2026
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Skilled Nursing Facilities
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing
      • Sponsored Content